[Rivaroxaban. The first factor Xa inhibitor].
Oberpichler-Schwenk
Heike
H
Redaktion Medizinische Monatsschrift für Pharmazeuten, Birkenwaldstr 44, 70191 Stuttgart. hoberpichler@deutscher-apotheker-verlag.de
D000818:Animals; D065427:Factor Xa Inhibitors; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D009025:Morpholines / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control; D000069552:Rivaroxaban; D013876:Thiophenes / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D013923:Thromboembolism / Q000517:prevention & control; D013927:Thrombosis / Q000517:prevention & control
D065427:Factor Xa Inhibitors; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban